Not applicableEnded earlyNCT00798837What this trial is testingIntraprostatic MAXimal Simultaneous BoostWho this might be right forProstate Cancer British Columbia Cancer Agency 10
Very early researchLooking for participantsNCT06759701What this trial is testingPre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility StudyWho this might be right forDiabetesProstate Cancer M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00193271What this trial is testingAdjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate CancerWho this might be right forProstate Cancer SCRI Development Innovations, LLC 30
Not applicableWithdrawnNCT03935308What this trial is testingPhase I Study MR-guided SBRT to PCaWho this might be right forLow or Intermediate Risk Prostate Cancer Henry Ford Health System
Not applicableLooking for participantsNCT05384535What this trial is testingUtility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortWho this might be right forProstate CancerMagnetic Resonance ImagingPopulation at Risk Northwell Health 100
Not applicableUnknownNCT03526510What this trial is testingHypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate CancerWho this might be right forProstate Cancer Dr. Patrick Cheung 178
Testing effectiveness (Phase 2)Study completedNCT03322020What this trial is testingAndrogen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate CancerWho this might be right forNeoplasm, Prostate Asan Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT03753243What this trial is testingNeoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate CancerWho this might be right forProstate Cancer Mark Garzotto, MD 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT00525720What this trial is testingBrachytherapy for Prostatic Carcinoma PatientsWho this might be right forProstate Cancer M.D. Anderson Cancer Center 300
Large-scale testing (Phase 3)Study completedNCT00116220What this trial is testingStudy of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate CancerWho this might be right forProstate Cancer Dana-Farber Cancer Institute 206
Testing effectiveness (Phase 2)Looking for participantsNCT07182279What this trial is testingNeoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate CancerWho this might be right forProstate Cancer (Adenocarcinoma) The Methodist Hospital Research Institute 29
Testing effectiveness (Phase 2)Looking for participantsNCT05361798What this trial is testingT-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation TherapyWho this might be right forCancer Of Prostate National Cancer Institute (NCI) 65
Large-scale testing (Phase 3)Looking for participantsNCT05448547What this trial is testingImmediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerWho this might be right forProstate Cancer Sven Löffeler 980
Not applicableStudy completedNCT00573833What this trial is testingInternal Radiation Therapy in Treating Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT02200614What this trial is testingEfficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerWho this might be right forProstate Cancer Non-MetastaticCastration-Resistant Bayer 1,509
Early research (Phase 1)Active Not RecruitingNCT02023463What this trial is testingEnzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate CancerWho this might be right forAdenocarcinoma of the ProstateRecurrent Prostate CancerStage IIB Prostate Cancer+2 more Thomas Jefferson University 25
Not applicableActive Not RecruitingNCT01342367What this trial is testingFeasibility of Hormones and Radiation for Intermediate or High Risk Prostate CancerWho this might be right forProstate Cancer University of Chicago 74
Not applicableActive Not RecruitingNCT03383016What this trial is testingDiet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE)Who this might be right forEpidemiologyProstate Cancer CHU de Quebec-Universite Laval 2,053
Not applicableLooking for participantsNCT06220435What this trial is testingTumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate CancerWho this might be right forProstate Cancer Region Skane 76
Not applicableNot Yet RecruitingNCT07398690What this trial is testingOPTIMUM-PCa: MRI- and PHI-Guided Prostate Cancer DiagnosisWho this might be right forProstate Cancer (Diagnosis)Prostate Cancer In Gab Jeong, MD 1,432